daunorubicin has been researched along with Colitis, Ulcerative in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berenberg, J; Cooper, MR; Cornell, C; Dosik, H; Ellison, RR; Falkson, G; Frelick, R; Glidewell, O; Gottlieb, A; Green, M; Haurani, F; Henderson, E; Henry, P; Hoagland, C; Holland, JF; Hutchison, JL; James, GW; Leone, L; Levy, R; Nissen, N; Raich, P; Silver, RT; Steinberg, D; Wiernik, P; Yates, J | 1 |
1 trial(s) available for daunorubicin and Colitis, Ulcerative
Article | Year |
---|---|
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Colitis, Ulcerative; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomatitis | 1982 |